Cytokeratin 18 Antibody (YA3660)
(Synonyms: CK18; CYK18; KRT18)Based on 1 Customer Validation
Cytokeratin 18 Antibody (YA3660) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to Cytokeratin 18.
-
Host:
Mouse
-
Isotype:
IgG2b
-
Application:
WB, IHC-P, ELISA
-
Reactivity :
Human
-
Formulation:
Supplied in PBS with 0.05% sodium azide.
-
Conjugation:
Non-conjugated
Applications
| Application |
WB
WB: Western Blot
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
|---|---|---|---|
| Dilution Ratio | 1:500-1:2000 | 1:200-1:1000 | 1:10000 |
Product Details
Cytokeratin 18 Antibody (YA3660) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to Cytokeratin 18.
-
Host Mouse
-
Clonality Monoclonal
-
Species ReactivityHuman
-
Observed Molecular WeightObserved band size: 48 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 48 kDa
Purified recombinant fragment of human Cytokeratin 18 (aa391-483) expressed in E. Coli.
affinity purified.
Non-conjugated
Unmodified
IgG2b
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in PBS with 0.05% sodium azide.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Background
-
Function
Cytokeratin 18 is involved in the uptake of thrombin-antithrombin complexes by hepatic cells. When phosphorylated, plays a role in filament reorganization. Involved in the delivery of mutated CFTR to the plasma membrane. Together with KRT8, is involved in interleukin-6 (IL-6)-mediated barrier protection
-
Subcellular Localization
Nucleus matrix; Cytoplasm, perinuclear region; Nucleus, nucleolus; Cytoplasm
-
Expression
Tissue_specificity:It is expressed in the colon, placenta, and liver, with very weak expression at the external os of the cervix. Increased expression has been observed in breast cancer lymph nodes.
Induction:By IL6/interleukin-6 -
Subunit
Heterotetramer of two type I and two type II keratins. KRT18 associates with KRT8 (PubMed:10852826, PubMed:24940650). Interacts with PLEC isoform 1C, when in a heterodimer with KRT8 (PubMed:24940650).
-
SwissProt ID
-
Synonyms
CK18; CYK18; KRT18
Documentation